These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11173058)

  • 1. The impact of pharmacogenetics for migraine.
    Ophoff RA; van den Maagdenberg AM; Roon KI; Ferrari MD; Frants RR
    Eur J Pharmacol; 2001 Feb; 413(1):1-10. PubMed ID: 11173058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of migraine: implication for treatment approaches.
    Ferrari MD; Haan J
    J Neural Transm Suppl; 2002; (63):111-27. PubMed ID: 12597612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of migraine--a review of the literature].
    Marterer A; Wessely P
    Fortschr Neurol Psychiatr; 1995 Jan; 63(1):1-16. PubMed ID: 7883267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advances in migraine.
    Solomon GD
    J Clin Pharmacol; 1993 Mar; 33(3):200-9. PubMed ID: 8385160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of migraine: genetic variants and their potential role in migraine therapy.
    Fernandez F; Colson NJ; Griffiths LR
    Pharmacogenomics; 2007 Jun; 8(6):609-22. PubMed ID: 17559350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of medications used in treating headache.
    Solomon GD
    Semin Pediatr Neurol; 1995 Jun; 2(2):165-77. PubMed ID: 9422244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute drug treatment of migraine attack.
    Narbone MC; Abbate M; Gangemi S
    Neurol Sci; 2004 Oct; 25 Suppl 3():S113-8. PubMed ID: 15549517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; from CACNA1A to migraine].
    Kors EE; Haan J; Frants RR; Ferrari MD
    Ned Tijdschr Geneeskd; 2001 Feb; 145(6):266-7. PubMed ID: 11236374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine prophylaxis: who, why, and how.
    Loj J; Solomon GD
    Cleve Clin J Med; 2006 Sep; 73(9):793-4, 797, 800-1 passim. PubMed ID: 16970133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations.
    Lionetto L; Borro M; Curto M; Capi M; Negro A; Cipolla F; Gentile G; Martelletti P
    Expert Opin Drug Metab Toxicol; 2016; 12(4):399-406. PubMed ID: 26878379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine prophylactic drugs work via ion channels.
    Cohen GL
    Med Hypotheses; 2005; 65(1):114-22. PubMed ID: 15893128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale.
    Raskin NH
    Neurology; 1993 Jun; 43(6 Suppl 3):S39-42. PubMed ID: 8389010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-CGRP Antagonist/Non-Triptan Options for Migraine Disease Treatment: Clinical Considerations.
    Ingram EE; Bocklud BE; Corley SC; Granier MA; Neuchat EE; Ahmadzadeh S; Shekoohi S; Kaye AD
    Curr Pain Headache Rep; 2023 Oct; 27(10):497-502. PubMed ID: 37584847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine, migraine variants, and related headaches.
    Saper JR
    Otolaryngol Clin North Am; 1989 Dec; 22(6):1115-30. PubMed ID: 2574844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spanish study of quality of life in migraine (II). Profile of medication consumption and subjective efficacy].
    Pascual J; Leira R; Láinez JM; Alberca R; Titus F; Morales F; Díez-Tejedor E; García de Polavieja J
    Neurologia; 1999 May; 14(5):204-9. PubMed ID: 10377720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eye movement disorders are an early manifestation of CACNA1A mutations in children.
    Tantsis EM; Gill D; Griffiths L; Gupta S; Lawson J; Maksemous N; Ouvrier R; Riant F; Smith R; Troedson C; Webster R; Menezes MP
    Dev Med Child Neurol; 2016 Jun; 58(6):639-44. PubMed ID: 26814174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of migraine: from mechanisms of action to contraindications.
    Higelin F; Annoni JM
    Schweiz Med Wochenschr; 1998 Mar; 128(10):374-83. PubMed ID: 9556832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs in migraine treatment.
    Waeber C
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):437-56. PubMed ID: 14661998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine: a pharmacologic review with newer options and delivery modalities.
    Baumel B
    Neurology; 1994 May; 44(5 Suppl 3):S13-7. PubMed ID: 7911231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of therapy in hemicrania].
    Sternieri E; Ferrari A
    Ann Ital Med Int; 1992; 7(3 Suppl):46S-63S. PubMed ID: 1363626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.